Gene · 1398
Papers2,784
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,784
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Focal adhesion kinase: from biological functions to therapeutic strategies. | Exp Hematol Oncol | 2023 | 37749625 | PubTator, text mining | PubMed |
| Abl kinases can function as suppressors of tumor progression and metastasis. | Front Oncol | 2023 | 37746268 | PubTator, text mining | PubMed |
| Complement factor D regulates collagen type I expression and fibroblast migration to enhance human tendon repair and healing outcomes. | Front Immunol | 2023 | 37744351 | PubTator, text mining | PubMed |
| Antimicrobial resistance, pathogenic potential, and genomic features of carbapenem-resistant Klebsiella pneumoniae isolated in Chile: high-risk ST25 clones and novel mobile elements. | Microbiol Spectr | 2023 | 37707451 | PubTator, text mining | PubMed |
| The spatiotemporal heterogeneity of the biophysical microenvironment during hematopoietic stem cell development: from embryo to adult. | Stem Cell Res Ther | 2023 | 37705072 | PubTator, text mining | PubMed |
| Crk and Crkl Are Required in the Endocardial Lineage for Heart Valve Development. | J Am Heart Assoc | 2023 | 37702066 | PubTator, text mining | PubMed |
| Dexamethasone suppression for 18F-FDG PET/CT to localize ACTH-secreting pituitary tumors. | Cancer Imaging | 2023 | 37700359 | PubTator, text mining | PubMed |
| IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway. | Cancers (Basel) | 2023 | 37686528 | PubTator, text mining | PubMed |
| The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations. | Cancers (Basel) | 2023 | 37686522 | PubTator, text mining | PubMed |
| THBS1-Mediated Degradation of Collagen via the PI3K/AKT Pathway Facilitates the Metastasis and Poor Prognosis of OSCC. | Int J Mol Sci | 2023 | 37686118 | PubTator, text mining | PubMed |
| Insulin signaling and its application. | Front Endocrinol (Lausanne) | 2023 | 37664840 | PubTator, text mining | PubMed |
| Dynamics of training and acute exercise-induced shifts in muscular glucose transporter (GLUT) 4, 8, and 12 expression in locomotion versus posture muscles in healthy horses. | Front Physiol | 2023 | 37654675 | PubTator, text mining | PubMed |
| Altered Proteomic Profile of Exosomes Secreted from Vero Cells Infected with Porcine Epidemic Diarrhea Virus. | Viruses | 2023 | 37631983 | PubTator, text mining | PubMed |
| Oxidative Stress and Its Regulation in Diabetic Retinopathy. | Antioxidants (Basel) | 2023 | 37627644 | PubTator, text mining | PubMed |
| The Unfolded Protein Response: A Double-Edged Sword for Brain Health. | Antioxidants (Basel) | 2023 | 37627643 | PubTator, text mining | PubMed |
| The Role of GAB1 in Cancer. | Cancers (Basel) | 2023 | 37627207 | PubTator, text mining | PubMed |
| A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling. | Cells | 2023 | 37626864 | PubTator, text mining | PubMed |
| Urine-mediated suppression of Klebsiella pneumoniae mucoidy is counteracted by spontaneous Wzc variants altering capsule chain length. | mSphere | 2023 | 37610214 | PubTator, text mining | PubMed |
| Advances in the Application of Apoptotic Proteins and Alternative Splicing in Tumor Therapy: A Narrative Review. | Iran J Public Health | 2023 | 37593500 | PubTator, text mining | PubMed |
| EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets. | Cancers (Basel) | 2023 | 37568780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1398/papers?page=6